Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Transplantation

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 20 articles: HTML format

Single Articles

March 2026
1. BAJAJ JS, Jakab SS, Jesudian AB, Rahimi RS, et al
   ACG Clinical Guideline: Hepatic Encephalopathy.
   Am J Gastroenterol. 2026;121:588-618.
   PubMed     Abstract available
   
   
   September 2025
2. HASJIM BJ, Patel M, Chen S, Ichii H, et al
   Social Determinants of Health and Liver Transplant Outcomes in U.S. Indigenous Populations.
   Am J Gastroenterol. 2025 Sep 26. doi: 10.14309/ajg.0000000000003770.
   PubMed     Abstract available
   
   
   July 2025
3. VEYRE F, De Martin E, Erard D, Francoz C, et al
   Recurrence of primary sclerosing cholangitis after liver transplantation: a French national cohort study including 571 patients.
   Am J Gastroenterol. 2025 Jul 24. doi: 10.14309/ajg.0000000000003659.
   PubMed     Abstract available
   
   
   June 2025
4. SOGBE M, Wong R, Bloomer PM, Steinberg A, et al
   Psychomotor speed from minimal hepatic encephalopathy testing is associated with physical frailty in patients with advanced chronic liver disease.
   Am J Gastroenterol. 2025 Jun 9. doi: 10.14309/ajg.0000000000003583.
   PubMed     Abstract available
   
   
   May 2025
5. XU L, Shen X
   Retraction: Effects of Cholestasis on Primary Sclerosing Cholangitis in Patients Following Liver Transplantation: Insights From Mixed Censoring Outcomes.
   Am J Gastroenterol. 2025 May 21. doi: 10.14309/ajg.0000000000003516.
   PubMed    
   
   
   April 2025
6. GAO M, Ma X
   Accurately Predicting Recurrent Primary Sclerosing Cholangitis After Liver Transplantation.
   Am J Gastroenterol. 2025 Apr 7. doi: 10.14309/ajg.0000000000003423.
   PubMed    
   
   
   February 2025
7. XU L, Shen X, Xu Y
   Effects of Cholestasis on Primary Sclerosing Cholangitis in Patients Following Liver Transplantation: Insights From Mixed Censoring Outcomes.
   Am J Gastroenterol. 2025 Feb 5. doi: 10.14309/ajg.0000000000003313.
   PubMed    
   
   
   
8. AZIZ B, Kok B, Cheah M, Lytvyak E, et al
   Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.
   Am J Gastroenterol. 2025;120:459-468.
   PubMed     Abstract available
   
   
   December 2024
9. SINGAL AK, Pannerselvam D, Arab JP, Im G, et al
   Delisting From Liver Transplant List for Improvement and Re-compensation Among Decompensated Patients at one-year.
   Am J Gastroenterol. 2024 Dec 23. doi: 10.14309/ajg.0000000000003259.
   PubMed     Abstract available
   
   
   November 2024
10. KOHLI DR, Amateau S
    Judicious Use of Antibiotics in Liver Transplant Recipients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Am J Gastroenterol. 2024 Nov 25. doi: 10.14309/ajg.0000000000003185.
    PubMed    
    
    
    October 2024
11. BHUSHAN S, Sohal A, Kowdley KV, Agaf FF, et al
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape.
    Am J Gastroenterol. 2024 Oct 31. doi: 10.14309/ajg.0000000000003174.
    PubMed     Abstract available
    
    
    
12. HASJIM BJ, Harris A, Balbale SN, Obayemi JE, et al
    Social Disadvantage and Disparities in Chronic Liver Disease: A Systematic Review.
    Am J Gastroenterol. 2024;120:1548-1566.
    PubMed     Abstract available
    
    
    
13. ZAVER HB, Rajpal N, Shah NL, Argo CK, et al
    MELD and MELD 3.0: What It Means for Your Practice.
    Am J Gastroenterol. 2024;119:1951-1954.
    PubMed    
    
    
    August 2024
14. KOWDLEY KV, Hirschfield GM, Coombs C, Malecha ES, et al
    COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
    Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003029.
    PubMed     Abstract available
    
    
    July 2024
15. AZIZ B, Kok B, Cheah M, Lytvyak E, et al
    Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.
    Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002977.
    PubMed     Abstract available
    
    
    
16. DUKEWICH M, Dodge JL, Lucey MR, Rice JP, et al
    The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center ACCELERATE Study.
    Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002956.
    PubMed     Abstract available
    
    
    
17. LEE WM, Barnard C, Rule JA, Orandi BJ, et al
    Association of Acetaminophen (Paracetamol) Use with Severity and Outcomes in Patients with Viral Hepatitis-Associated Acute Liver Failure.
    Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002941.
    PubMed     Abstract available
    
    
    
18. ARTZNER T, Goldberg DS, Sundaram V, Faitot F, et al
    Improvement in survival after transplantation for critically ill patients with cirrhosis in the United States.
    Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002944.
    PubMed     Abstract available
    
    
    June 2024
19. ELHENCE H, Dodge JL, Kahn JA, Lee BP, et al
    Characteristics and Outcomes Among U.S. Commercially Insured Transgender Adults with Cirrhosis: A National Cohort Study.
    Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002907.
    PubMed     Abstract available
    
    
    September 2023
20. NACHEF C, Bousson V, Belmatoug N, Cohen-Solal M, et al
    Osteoporosis and fragility fractures in patients with cirrhosis evaluated for liver transplantation: Identification of high-risk patients based on computed tomography at evaluation.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002507.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum